• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/30; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/30; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 401766
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/03/2022
Type of Reportable Event Malfunction
Event or Problem Description
An orsiro drug-eluting stent system was selected for treatment.Stent came off the wire with the removal of the stent protective cover before insertion.The stent fell outside of the sterile field.
 
Additional Manufacturer Narrative
Combination product: yes.
 
Additional Manufacturer Narrative
Combination product: yes only the stent was returned and subjected to a technical investigation.The product release documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The stent was returned unprotected in a plastic bag.The stent is deformed (i.E.Kinked twice) in its center.Both the delivery system and the stent protector were not returned for analysis.Review of the product release documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO (US) 2.5/30
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key15679508
Report Number1028232-2022-05485
Device Sequence Number12252365
Product Code NIQ
UDI-Device Identifier07640130439214
UDI-Public(01)07640130439214(17)2308
Combination Product (Y/N)Y
Initial Reporter CountryCH
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/10/2023
Device Model Number401766
Device Catalogue NumberSEE MODEL NO.
Device Lot Number07210327
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/21/2022
Supplement Date Received by Manufacturer11/09/2022
Initial Report FDA Received Date10/27/2022
Supplement Report FDA Received Date11/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/10/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-